Home > Insider Trading > Filing (0001140361-15-006591)

Filing Details

Accession Number:: 0001140361-15-006591
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-13 16:16:10
Reporting Period:: 2015-02-11

Filing Date:: 2015-02-13
Accepted Time:: 2015-02-13 16:16:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184149	W Jonathan Ayers	One Idexx Drive Westbrook ME 04092	Chairman, President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-02-11	29,000	$56.95	460,130	No	4	M	Direct
Common Stock	Disposition	2015-02-11	10,218	$154.01	449,912	No	4	S	Direct
Common Stock	Disposition	2015-02-11	16,231	$154.83	433,681	No	4	S	Direct
Common Stock	Disposition	2015-02-11	2,551	$155.72	431,130	No	4	S	Direct
Common Stock	Acquisiton	2015-02-12	29,245	$56.95	460,375	No	4	M	Direct
Common Stock	Disposition	2015-02-12	22,877	$156.16	437,498	No	4	S	Direct
Common Stock	Disposition	2015-02-12	5,768	$156.59	431,730	No	4	S	Direct
Common Stock	Disposition	2015-02-12	600	$157.48	431,130	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-02-11	29,000	$0.00	29,000	$56.95
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2015-02-12	29,245	$0.00	29,245	$56.95

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
29,245		2015-02-13	No	4	M	Direct
0		2015-02-13	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	49,000	Indirect	By Ayers Family Trust

Footnotes

The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/28/2014.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $153.32 to $154.31, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 7, inclusive, to this Form 4.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $154.32 to $155.31, inclusive.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $155.38 to $155.83, inclusive.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $155.46 to $156.45, inclusive.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $156.46 to $156.84, inclusive.
The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $157.46 to $157.49, inclusive.
Grant of options to buy shares of common stock that became exercisable as to 12,000 shares on 02/14/2009, 02/14/2010, 02/14/2011 and 02/14/2012, and 10,245 shares on 02/14/2013.